Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06016140
Other study ID # 2022-04430-01
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 1, 2022
Est. completion date November 1, 2023

Study information

Verified date January 2024
Source Region Jönköping County
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Harm from medications is still a concern in an aged population. As medication treatment for older persons many times are complex, a feasibility study can be helpful to support decisions about future evaluation and implementation of an intervention. In this study, the overall aim is to assess feasibility, acceptability and potential effects of usage of a co-designed medication plan for older persons with medication treatment. The study will take place in the primary care setting in Sweden, and involve persons 75 years or older using five or more medications on daily basis, physicians at primary care centers and persons supporting the older person in their medication use a home. During an appointment, the physician and older person will agree on a medication plan, that will be documented in the older person's electronic health record and printed out on paper. After three month, the potential outcomes of a medication plan will be collected, together with data about feasibility and acceptability of the intervention. Two questionnaires will be used, addressing usability and patient safety. Moreover, remote interviews with participants will be performed to address usability and patient safety. Information about the medication plan will be collected from the electronic health record. Data analysis will be done with descriptive statistics and qualitative content analysis. Expected outcomes are an assessment of feasibility and acceptability, and potential outcomes, to support decision on a future evaluation of the medication plan.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date November 1, 2023
Est. primary completion date September 1, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Physicians and nurses: regular contact with the older person regarding medications, employment at a primary care center and ability to understand and communicate in Swedish - Older persons: age >75 years old, five or more medications on a regular basis and ability to understand and communicate in Swedish - Next-of-kin: age > 18 years old, regular contact with the older person regarding medications, ability to understand and communicate in Swedish Exclusion Criteria: - Older persons: impaired cognitive ability affecting the ability to provide informed consent (Diagnosis code for dementia) and late palliative phase, here defined as estimated life expectancy shorter than six months - Next-of-kin: impaired cognitive ability affecting the ability to provide informed consent

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Medication plan
Involved participants will jointly agreed on continued medication treatment (treatment aim, planned monitring and evaluation and responsibility, and the physician will document the plan in the electronic health record

Locations

Country Name City State
Sweden Region Jonkoping County Jönköping

Sponsors (2)

Lead Sponsor Collaborator
Region Jönköping County Jonkoping University

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Primary Feasibility of the intervention For feasibility of the intervention, the secondary outcome measures will be analyzed together to address the feasibility of chosen study methods and of the intervention of using a co-designed medication plan Three months
Secondary Usability of the medication plan A modified version of Brookes "The System Usability Scale, SUS" will be used to measure usability of the medication plan. SUS is a widely used questionnaire for measuring the perception of the user experience and has been translated and evaluated in Swedish. The questions will be distributed by e-mail or mail (which is preferred of the participants) at the end of the three-month follow-up period. Three months
Secondary Usability of the medication plan Semi-structured interviews, with questions addressing usability will be conducted with participants (older persons, next-of-kin, physicians, nurses) at the end of the three-month follow-up period. The interview guide will be guided by topics addressed in SUS. A strategic selection of all participants will be used to gather different experiences. The interviews will be audio-recorded and then will be transcribed verbatim. Three months
Secondary Patient safety We will use a selected number of questions, which addresses concerns related to safety, from the Swedish National Patient survey in primary care, and ask the older persons to complete the questionnaire. No similar measurement will be used for healthcare professionals and next-of-kin. Three months
Secondary Patient safety We will complement the questionnaire with semi-structured interviews performed with older persons, nurses, next-of-kin and physicians. Questions addressing patient safety will be asked to the same population and at the same occasion as the interviews about usability. The interview guide will be guided by questions in the Swedish National Patient survey and inspired by indicators for safety monitoring in healthcare as proposed by Vincent et al. Three months
Secondary Acceptability of the intervention Acceptability of the intervention will be assessed by collecting the number of completed and adjusted medication plans, the content in the medication plans and medications prescribed for each older person during the follow up period Three months
Secondary Healthcare utilisation Healthcare utilisation will be measured as number and cause, of hospital admission, emergency visits and unplanned physician visits during the follow up period Three months
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06043895 - EpiFaith CV for Central Venous Catheterization N/A
Not yet recruiting NCT05958108 - Effectivenness and Implementation of an Intervention to Improve Primary Care Patient Safety Phase 3
Recruiting NCT02574104 - Generalizing TESTPILOT to New Single Family Room NICUs N/A
Completed NCT00599209 - Health Information Technology in the Nursing Home N/A
Completed NCT04576299 - Health Care Workers' Perception of Patient Safety During COVID-19 Pandemic
Completed NCT03663491 - Necessity of Transnasal Gastroscopy in Routine Diagnostics - a Patient Centered Requirement Analysis N/A
Completed NCT00212927 - Continuity of Care and Outcomes After Discharge From Hospital N/A
Not yet recruiting NCT05062434 - An Intervention to Impact Cardiovascular Implantable Electronic Device Lead Models Implanted in Veterans N/A
Recruiting NCT06089239 - De-Implementing Fall Prevention Alarms in Hospitals N/A
Recruiting NCT04861025 - Siderails as a Measure of Physical Restraint. GERBAR Trial
Completed NCT04990986 - Co-Development and Evaluation of a Complex Intervention to Increase Medication Safety in Nursing Homes N/A
Recruiting NCT02955836 - Effectiveness of Monitoring Information System of Nursing Related Patient Safety and Quality Indicators N/A
Completed NCT01246544 - Helsinki Declaration on Patient Safety N/A
Recruiting NCT05530187 - ePRO-based Model of Care to Manage and Monitoring Symptoms of Cancer Patients Treated With Immune Checkpoint Inhibitors N/A
Recruiting NCT04176094 - Intensive Care Unit Resident Scheduling Trial N/A
Completed NCT05794490 - Learning From Excellence in a Hospital Unit
Recruiting NCT06269250 - Acceptance and Perceived Benefits of Digitalization by Medical Assistants
Recruiting NCT03105713 - Development and Implementation of Patient Safety Checklists Before, During and After In-hospital Surgery N/A
Completed NCT04184570 - Audit of International Intraoperative Hemotherapy and Blood Loss Documentation
Recruiting NCT04897087 - Openness and Learning Joint Commission: Using Patient Experience for Improvement Following a Patient Safety Event